Cohort_1 (n = 21) | Cohort_2 (n = 23) | Cohort_3 (n = 73) | |
---|---|---|---|
Gender | |||
Male (%) | 61.9 | 30.4 | 53.4 |
Female(%) | 38.1 | 69.6 | 46.6 |
Age (Range) | 67 (52–79) | 67 (47–84) | 65 (40–82) |
Stage | |||
I-II (%) | / | / | 28.7 |
III (%) | 57.1 | 56.5 | 39.7 |
IV(%) | 42.9 | 43.5 | 31.6 |
Tumor site | |||
Head | 43.3 | 26.1 | 64.7 |
Body | 29.0 | 47.8 | 19.1 |
Tail | 19.0 | 17.4 | 6.8 |
Multi localized | 8.7 | 8.7 | 9.4 |
The total number of cases, the male/female percentage, the mean age (years) with minimum and maximum value (range), stage and tumor localization of the three cohorts of PDAC patients. In each cohort, PDAC patients were compared to a cohort of age- and gender-matched healthy donors